199 related articles for article (PubMed ID: 24173428)
21. The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo.
Merdzhanova G; Gout S; Keramidas M; Edmond V; Coll JL; Brambilla C; Brambilla E; Gazzeri S; Eymin B
Oncogene; 2010 Sep; 29(39):5392-403. PubMed ID: 20639906
[TBL] [Abstract][Full Text] [Related]
22. CD44 expression patterns in breast and colon tumors: a PCR-based study of splice variants.
Rodriguez C; Monges G; Rouanet P; Dutrillaux B; Lefrançois D; Theillet C
Int J Cancer; 1995 Oct; 64(5):347-54. PubMed ID: 7591309
[TBL] [Abstract][Full Text] [Related]
23. Antagonistic roles of four SR proteins in the biosynthesis of alternatively spliced tissue factor transcripts in monocytic cells.
Chandradas S; Deikus G; Tardos JG; Bogdanov VY
J Leukoc Biol; 2010 Jan; 87(1):147-52. PubMed ID: 19843576
[TBL] [Abstract][Full Text] [Related]
24. Splicing factor Tra2-beta1 is specifically induced in breast cancer and regulates alternative splicing of the CD44 gene.
Watermann DO; Tang Y; Zur Hausen A; Jäger M; Stamm S; Stickeler E
Cancer Res; 2006 May; 66(9):4774-80. PubMed ID: 16651431
[TBL] [Abstract][Full Text] [Related]
25. mRNA expression analysis confirms CD44 splicing impairment in systemic lupus erythematosus patients.
Latini A; Novelli L; Ceccarelli F; Barbati C; Perricone C; De Benedittis G; Conti F; Novelli G; Ciccacci C; Borgiani P
Lupus; 2021 Jun; 30(7):1086-1093. PubMed ID: 33794704
[TBL] [Abstract][Full Text] [Related]
26. Differential recruitment of pre-mRNA splicing factors to alternatively spliced transcripts in vivo.
Mabon SA; Misteli T
PLoS Biol; 2005 Nov; 3(11):e374. PubMed ID: 16231974
[TBL] [Abstract][Full Text] [Related]
27. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM
Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884
[TBL] [Abstract][Full Text] [Related]
28. Cyclic AMP-dependent protein kinase enhances SC35-promoted Tau exon 10 inclusion.
Chen C; Jin N; Qian W; Liu W; Tan X; Ding F; Gu X; Iqbal K; Gong CX; Zuo J; Liu F
Mol Neurobiol; 2014 Feb; 49(1):615-24. PubMed ID: 24037441
[TBL] [Abstract][Full Text] [Related]
29. Gene therapeutic approach to primary and metastatic brain tumors: I. CD44 variant pre-RNA alternative splicing as a CEPT control element.
Asman DC; Dirks JF; Ge L; Resnick NM; Salvucci LA; Gau JT; Becich MJ; Cooper DL; Dougherty GJ
J Neurooncol; 1995 Dec; 26(3):243-50. PubMed ID: 8750190
[TBL] [Abstract][Full Text] [Related]
30. Depletion of Arabidopsis SC35 and SC35-like serine/arginine-rich proteins affects the transcription and splicing of a subset of genes.
Yan Q; Xia X; Sun Z; Fang Y
PLoS Genet; 2017 Mar; 13(3):e1006663. PubMed ID: 28273088
[TBL] [Abstract][Full Text] [Related]
31. Multisite and bidirectional exonic splicing enhancer in CD44 alternative exon v3.
Vela E; Hilari JM; Roca X; Muñoz-Mármol AM; Ariza A; Isamat M
RNA; 2007 Dec; 13(12):2312-23. PubMed ID: 17940137
[TBL] [Abstract][Full Text] [Related]
32. hnRNP L inhibits CD44 V10 exon splicing through interacting with its upstream intron.
Loh TJ; Cho S; Moon H; Jang HN; Williams DR; Jung DW; Kim IC; Ghigna C; Biamonti G; Zheng X; Shen H
Biochim Biophys Acta; 2015 Jun; 1849(6):743-50. PubMed ID: 25623890
[TBL] [Abstract][Full Text] [Related]
33. E2F1 controls alternative splicing pattern of genes involved in apoptosis through upregulation of the splicing factor SC35.
Merdzhanova G; Edmond V; De Seranno S; Van den Broeck A; Corcos L; Brambilla C; Brambilla E; Gazzeri S; Eymin B
Cell Death Differ; 2008 Dec; 15(12):1815-23. PubMed ID: 18806759
[TBL] [Abstract][Full Text] [Related]
34. Growth hormone deficiency and splicing fidelity: two serine/arginine-rich proteins, ASF/SF2 and SC35, act antagonistically.
Solis AS; Peng R; Crawford JB; Phillips JA; Patton JG
J Biol Chem; 2008 Aug; 283(35):23619-26. PubMed ID: 18586677
[TBL] [Abstract][Full Text] [Related]
35. A novel CDX2 isoform regulates alternative splicing.
Witek ME; Snook AE; Lin JE; Blomain ES; Xiang B; Magee MS; Waldman SA
PLoS One; 2014; 9(8):e104293. PubMed ID: 25101906
[TBL] [Abstract][Full Text] [Related]
36. CD44 splicing pattern is associated with disease progression in pulmonary adenocarcinoma.
Lee LN; Kuo SH; Lee YC; Chang YL; Chang HC; Jan IS; Yang PC
J Formos Med Assoc; 2005 Aug; 104(8):541-8. PubMed ID: 16193174
[TBL] [Abstract][Full Text] [Related]
37. Regulation of Ich-1 pre-mRNA alternative splicing and apoptosis by mammalian splicing factors.
Jiang ZH; Zhang WJ; Rao Y; Wu JY
Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9155-60. PubMed ID: 9689050
[TBL] [Abstract][Full Text] [Related]
38. Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF.
Mayeda A; Helfman DM; Krainer AR
Mol Cell Biol; 1993 May; 13(5):2993-3001. PubMed ID: 8474457
[TBL] [Abstract][Full Text] [Related]
39. Influence of intron length on alternative splicing of CD44.
Bell MV; Cowper AE; Lefranc MP; Bell JI; Screaton GR
Mol Cell Biol; 1998 Oct; 18(10):5930-41. PubMed ID: 9742110
[TBL] [Abstract][Full Text] [Related]
40. Uterine expression of alternatively spliced mRNAs of mouse splicing factor SC35 during early pregnancy.
Nie GY; Li Y; Batten L; Griffiths B; Wang J; Findlay JK; Salamonsen LA
Mol Hum Reprod; 2000 Dec; 6(12):1131-9. PubMed ID: 11101696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
